Detalles de la búsqueda
1.
Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.
BMC Med
; 20(1): 187, 2022 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35550592
2.
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state.
Cancer Sci
; 111(6): 1876-1886, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32187778
3.
Survival-associated alternative splicing signatures in esophageal carcinoma.
Carcinogenesis
; 40(1): 121-130, 2019 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30304323
4.
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
J Transl Med
; 17(1): 430, 2019 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31888670
5.
Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.
BMC Med
; 20(1): 265, 2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35883140
6.
Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators.
Cancer Cell
; 42(6): 1106-1125.e8, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38788718
7.
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Front Immunol
; 13: 909105, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35603152
8.
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.
Cancer Commun (Lond)
; 42(9): 828-847, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35811500
9.
Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Front Immunol
; 13: 783495, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35222371
10.
Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.
Ther Adv Med Oncol
; 13: 17588359211006949, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33889215
11.
Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer.
Front Immunol
; 12: 782106, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34868057
12.
A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma.
Cancer Biol Med
; 2021 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33856140
13.
TGF-ß-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.
Cell Death Dis
; 12(10): 901, 2021 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34601488
14.
The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non-small-cell lung cancer.
Clin Transl Immunology
; 10(1): e1231, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33425353
15.
Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1.
Transl Lung Cancer Res
; 10(7): 3155-3172, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430355
16.
S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis.
Clin Transl Med
; 11(7): e459, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34323409
17.
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Cancer Biol Med
; 17(3): 768-781, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32944405
18.
Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
Cancer Lett
; 483: 46-58, 2020 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272148
19.
Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer.
J Exp Clin Cancer Res
; 39(1): 193, 2020 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32958011
20.
Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer.
Clin Transl Med
; 10(3): e128, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32659050